Global Anti-Obesity Drugs (Anti-obesity Medication) Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Anti-Obesity Drugs (Anti-obesity Medication) by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Anti-Obesity Drugs (Anti-obesity Medication) by Country/Region, 2017, 2022 & 2028

2.2 Anti-Obesity Drugs (Anti-obesity Medication) Segment by Type

2.2.1 Prescription Drugs

2.2.2 OTC Drugs

2.3 Anti-Obesity Drugs (Anti-obesity Medication) Sales by Type

2.3.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Type (2017-2022)

2.3.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue and Market Share by Type (2017-2022)

2.3.3 Global Anti-Obesity Drugs (Anti-obesity Medication) Sale Price by Type (2017-2022)

2.4 Anti-Obesity Drugs (Anti-obesity Medication) Segment by Application

2.4.1 Childhood (0-6)

2.4.2 Juvenile (7-17)

2.4.3 Youth (18-40)

2.4.4 Middle Aged (41-60)

2.4.5 Elderly (Above 60)

2.5 Anti-Obesity Drugs (Anti-obesity Medication) Sales by Application

2.5.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Sale Market Share by Application (2017-2022)

2.5.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue and Market Share by Application (2017-2022)

2.5.3 Global Anti-Obesity Drugs (Anti-obesity Medication) Sale Price by Application (2017-2022)

3 Global Anti-Obesity Drugs (Anti-obesity Medication) by Company

3.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Breakdown Data by Company

3.1.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Annual Sales by Company (2020-2022)

3.1.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Company (2020-2022)

3.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Annual Revenue by Company (2020-2022)

3.2.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Company (2020-2022)

3.2.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share by Company (2020-2022)

3.3 Global Anti-Obesity Drugs (Anti-obesity Medication) Sale Price by Company

3.4 Key Manufacturers Anti-Obesity Drugs (Anti-obesity Medication) Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Anti-Obesity Drugs (Anti-obesity Medication) Product Location Distribution

3.4.2 Players Anti-Obesity Drugs (Anti-obesity Medication) Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Anti-Obesity Drugs (Anti-obesity Medication) by Geographic Region

4.1 World Historic Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Geographic Region (2017-2022)

4.1.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Annual Revenue by Geographic Region

4.2 World Historic Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Country/Region (2017-2022)

4.2.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Annual Sales by Country/Region (2017-2022)

4.2.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Annual Revenue by Country/Region

4.3 Americas Anti-Obesity Drugs (Anti-obesity Medication) Sales Growth

4.4 APAC Anti-Obesity Drugs (Anti-obesity Medication) Sales Growth

4.5 Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales Growth

4.6 Middle East & Africa Anti-Obesity Drugs (Anti-obesity Medication) Sales Growth

5 Americas

5.1 Americas Anti-Obesity Drugs (Anti-obesity Medication) Sales by Country

5.1.1 Americas Anti-Obesity Drugs (Anti-obesity Medication) Sales by Country (2017-2022)

5.1.2 Americas Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Country (2017-2022)

5.2 Americas Anti-Obesity Drugs (Anti-obesity Medication) Sales by Type

5.3 Americas Anti-Obesity Drugs (Anti-obesity Medication) Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Anti-Obesity Drugs (Anti-obesity Medication) Sales by Region

6.1.1 APAC Anti-Obesity Drugs (Anti-obesity Medication) Sales by Region (2017-2022)

6.1.2 APAC Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Region (2017-2022)

6.2 APAC Anti-Obesity Drugs (Anti-obesity Medication) Sales by Type

6.3 APAC Anti-Obesity Drugs (Anti-obesity Medication) Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Anti-Obesity Drugs (Anti-obesity Medication) by Country

7.1.1 Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales by Country (2017-2022)

7.1.2 Europe Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Country (2017-2022)

7.2 Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales by Type

7.3 Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Anti-Obesity Drugs (Anti-obesity Medication) by Country

8.1.1 Middle East & Africa Anti-Obesity Drugs (Anti-obesity Medication) Sales by Country (2017-2022)

8.1.2 Middle East & Africa Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Country (2017-2022)

8.2 Middle East & Africa Anti-Obesity Drugs (Anti-obesity Medication) Sales by Type

8.3 Middle East & Africa Anti-Obesity Drugs (Anti-obesity Medication) Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Anti-Obesity Drugs (Anti-obesity Medication)

10.3 Manufacturing Process Analysis of Anti-Obesity Drugs (Anti-obesity Medication)

10.4 Industry Chain Structure of Anti-Obesity Drugs (Anti-obesity Medication)

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Anti-Obesity Drugs (Anti-obesity Medication) Distributors

11.3 Anti-Obesity Drugs (Anti-obesity Medication) Customer

12 World Forecast Review for Anti-Obesity Drugs (Anti-obesity Medication) by Geographic Region

12.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size Forecast by Region

12.1.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Forecast by Region (2023-2028)

12.1.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Anti-Obesity Drugs (Anti-obesity Medication) Forecast by Type

12.7 Global Anti-Obesity Drugs (Anti-obesity Medication) Forecast by Application

13 Key Players Analysis

13.1 Zafgan

13.1.1 Zafgan Company Information

13.1.2 Zafgan Anti-Obesity Drugs (Anti-obesity Medication) Product Offered

13.1.3 Zafgan Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Zafgan Main Business Overview

13.1.5 Zafgan Latest Developments

13.2 Vivus

13.2.1 Vivus Company Information

13.2.2 Vivus Anti-Obesity Drugs (Anti-obesity Medication) Product Offered

13.2.3 Vivus Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Vivus Main Business Overview

13.2.5 Vivus Latest Developments

13.3 Shionogi

13.3.1 Shionogi Company Information

13.3.2 Shionogi Anti-Obesity Drugs (Anti-obesity Medication) Product Offered

13.3.3 Shionogi Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Shionogi Main Business Overview

13.3.5 Shionogi Latest Developments

13.4 Sanofi

13.4.1 Sanofi Company Information

13.4.2 Sanofi Anti-Obesity Drugs (Anti-obesity Medication) Product Offered

13.4.3 Sanofi Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Sanofi Main Business Overview

13.4.5 Sanofi Latest Developments

13.5 Rhythm Pharmaceuticals

13.5.1 Rhythm Pharmaceuticals Company Information

13.5.2 Rhythm Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Product Offered

13.5.3 Rhythm Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Rhythm Pharmaceuticals Main Business Overview

13.5.5 Rhythm Pharmaceuticals Latest Developments

13.6 Pfizer

13.6.1 Pfizer Company Information

13.6.2 Pfizer Anti-Obesity Drugs (Anti-obesity Medication) Product Offered

13.6.3 Pfizer Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Pfizer Main Business Overview

13.6.5 Pfizer Latest Developments

13.7 Orexigen Therapeutics

13.7.1 Orexigen Therapeutics Company Information

13.7.2 Orexigen Therapeutics Anti-Obesity Drugs (Anti-obesity Medication) Product Offered

13.7.3 Orexigen Therapeutics Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Orexigen Therapeutics Main Business Overview

13.7.5 Orexigen Therapeutics Latest Developments

13.8 Novo Nordisk

13.8.1 Novo Nordisk Company Information

13.8.2 Novo Nordisk Anti-Obesity Drugs (Anti-obesity Medication) Product Offered

13.8.3 Novo Nordisk Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Novo Nordisk Main Business Overview

13.8.5 Novo Nordisk Latest Developments

13.9 Norgine

13.9.1 Norgine Company Information

13.9.2 Norgine Anti-Obesity Drugs (Anti-obesity Medication) Product Offered

13.9.3 Norgine Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Norgine Main Business Overview

13.9.5 Norgine Latest Developments

13.10 Nalpropion Pharmaceuticals Inc.

13.10.1 Nalpropion Pharmaceuticals Inc. Company Information

13.10.2 Nalpropion Pharmaceuticals Inc. Anti-Obesity Drugs (Anti-obesity Medication) Product Offered

13.10.3 Nalpropion Pharmaceuticals Inc. Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Nalpropion Pharmaceuticals Inc. Main Business Overview

13.10.5 Nalpropion Pharmaceuticals Inc. Latest Developments

13.11 Merck

13.11.1 Merck Company Information

13.11.2 Merck Anti-Obesity Drugs (Anti-obesity Medication) Product Offered

13.11.3 Merck Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Merck Main Business Overview

13.11.5 Merck Latest Developments

13.12 GlaxoSmithKline

13.12.1 GlaxoSmithKline Company Information

13.12.2 GlaxoSmithKline Anti-Obesity Drugs (Anti-obesity Medication) Product Offered

13.12.3 GlaxoSmithKline Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 GlaxoSmithKline Main Business Overview

13.12.5 GlaxoSmithKline Latest Developments

13.13 F.Hoffmann-La Roche

13.13.1 F.Hoffmann-La Roche Company Information

13.13.2 F.Hoffmann-La Roche Anti-Obesity Drugs (Anti-obesity Medication) Product Offered

13.13.3 F.Hoffmann-La Roche Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 F.Hoffmann-La Roche Main Business Overview

13.13.5 F.Hoffmann-La Roche Latest Developments

13.14 Eisai

13.14.1 Eisai Company Information

13.14.2 Eisai Anti-Obesity Drugs (Anti-obesity Medication) Product Offered

13.14.3 Eisai Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Eisai Main Business Overview

13.14.5 Eisai Latest Developments

13.15 Boehringer Ingelheim

13.15.1 Boehringer Ingelheim Company Information

13.15.2 Boehringer Ingelheim Anti-Obesity Drugs (Anti-obesity Medication) Product Offered

13.15.3 Boehringer Ingelheim Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Boehringer Ingelheim Main Business Overview

13.15.5 Boehringer Ingelheim Latest Developments

13.16 Bayer AG

13.16.1 Bayer AG Company Information

13.16.2 Bayer AG Anti-Obesity Drugs (Anti-obesity Medication) Product Offered

13.16.3 Bayer AG Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Bayer AG Main Business Overview

13.16.5 Bayer AG Latest Developments

13.17 AstraZeneca

13.17.1 AstraZeneca Company Information

13.17.2 AstraZeneca Anti-Obesity Drugs (Anti-obesity Medication) Product Offered

13.17.3 AstraZeneca Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 AstraZeneca Main Business Overview

13.17.5 AstraZeneca Latest Developments

13.18 Arena Pharmaceuticals

13.18.1 Arena Pharmaceuticals Company Information

13.18.2 Arena Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Product Offered

13.18.3 Arena Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue, Price and Gross Margin (2020-2022)

13.18.4 Arena Pharmaceuticals Main Business Overview

13.18.5 Arena Pharmaceuticals Latest Developments

13.19 Amylin

13.19.1 Amylin Company Information

13.19.2 Amylin Anti-Obesity Drugs (Anti-obesity Medication) Product Offered

13.19.3 Amylin Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue, Price and Gross Margin (2020-2022)

13.19.4 Amylin Main Business Overview

13.19.5 Amylin Latest Developments

13.20 Alizyme

13.20.1 Alizyme Company Information

13.20.2 Alizyme Anti-Obesity Drugs (Anti-obesity Medication) Product Offered

13.20.3 Alizyme Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue, Price and Gross Margin (2020-2022)

13.20.4 Alizyme Main Business Overview

13.20.5 Alizyme Latest Developments

14 Research Findings and Conclusion

Table 1. Anti-Obesity Drugs (Anti-obesity Medication) Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Anti-Obesity Drugs (Anti-obesity Medication) Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Prescription Drugs

Table 4. Major Players of OTC Drugs

Table 5. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales by Type (2017-2022) & (K Units)

Table 6. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Type (2017-2022)

Table 7. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Type (2017-2022) & ($ million)

Table 8. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share by Type (2017-2022)

Table 9. Global Anti-Obesity Drugs (Anti-obesity Medication) Sale Price by Type (2017-2022) & (USD/Unit)

Table 10. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales by Application (2017-2022) & (K Units)

Table 11. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Application (2017-2022)

Table 12. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Application (2017-2022)

Table 13. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share by Application (2017-2022)

Table 14. Global Anti-Obesity Drugs (Anti-obesity Medication) Sale Price by Application (2017-2022) & (USD/Unit)

Table 15. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales by Company (2020-2022) & (K Units)

Table 16. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Company (2020-2022)

Table 17. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share by Company (2020-2022)

Table 19. Global Anti-Obesity Drugs (Anti-obesity Medication) Sale Price by Company (2020-2022) & (USD/Unit)

Table 20. Key Manufacturers Anti-Obesity Drugs (Anti-obesity Medication) Producing Area Distribution and Sales Area

Table 21. Players Anti-Obesity Drugs (Anti-obesity Medication) Products Offered

Table 22. Anti-Obesity Drugs (Anti-obesity Medication) Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales by Geographic Region (2017-2022) & (K Units)

Table 26. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share Geographic Region (2017-2022)

Table 27. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales by Country/Region (2017-2022) & (K Units)

Table 30. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Country/Region (2017-2022)

Table 31. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Anti-Obesity Drugs (Anti-obesity Medication) Sales by Country (2017-2022) & (K Units)

Table 34. Americas Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Country (2017-2022)

Table 35. Americas Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share by Country (2017-2022)

Table 37. Americas Anti-Obesity Drugs (Anti-obesity Medication) Sales by Type (2017-2022) & (K Units)

Table 38. Americas Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Type (2017-2022)

Table 39. Americas Anti-Obesity Drugs (Anti-obesity Medication) Sales by Application (2017-2022) & (K Units)

Table 40. Americas Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Application (2017-2022)

Table 41. APAC Anti-Obesity Drugs (Anti-obesity Medication) Sales by Region (2017-2022) & (K Units)

Table 42. APAC Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Region (2017-2022)

Table 43. APAC Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share by Region (2017-2022)

Table 45. APAC Anti-Obesity Drugs (Anti-obesity Medication) Sales by Type (2017-2022) & (K Units)

Table 46. APAC Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Type (2017-2022)

Table 47. APAC Anti-Obesity Drugs (Anti-obesity Medication) Sales by Application (2017-2022) & (K Units)

Table 48. APAC Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Application (2017-2022)

Table 49. Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales by Country (2017-2022) & (K Units)

Table 50. Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Country (2017-2022)

Table 51. Europe Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share by Country (2017-2022)

Table 53. Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales by Type (2017-2022) & (K Units)

Table 54. Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Type (2017-2022)

Table 55. Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales by Application (2017-2022) & (K Units)

Table 56. Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Anti-Obesity Drugs (Anti-obesity Medication) Sales by Country (2017-2022) & (K Units)

Table 58. Middle East & Africa Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Anti-Obesity Drugs (Anti-obesity Medication) Sales by Type (2017-2022) & (K Units)

Table 62. Middle East & Africa Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Anti-Obesity Drugs (Anti-obesity Medication) Sales by Application (2017-2022) & (K Units)

Table 64. Middle East & Africa Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Anti-Obesity Drugs (Anti-obesity Medication)

Table 66. Key Market Challenges & Risks of Anti-Obesity Drugs (Anti-obesity Medication)

Table 67. Key Industry Trends of Anti-Obesity Drugs (Anti-obesity Medication)

Table 68. Anti-Obesity Drugs (Anti-obesity Medication) Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Anti-Obesity Drugs (Anti-obesity Medication) Distributors List

Table 71. Anti-Obesity Drugs (Anti-obesity Medication) Customer List

Table 72. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Forecast by Region (2023-2028) & (K Units)

Table 73. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Forecast by Region

Table 74. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Anti-Obesity Drugs (Anti-obesity Medication) Sales Forecast by Country (2023-2028) & (K Units)

Table 77. Americas Anti-Obesity Drugs (Anti-obesity Medication) Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Anti-Obesity Drugs (Anti-obesity Medication) Sales Forecast by Region (2023-2028) & (K Units)

Table 79. APAC Anti-Obesity Drugs (Anti-obesity Medication) Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales Forecast by Country (2023-2028) & (K Units)

Table 81. Europe Anti-Obesity Drugs (Anti-obesity Medication) Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Anti-Obesity Drugs (Anti-obesity Medication) Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Middle East & Africa Anti-Obesity Drugs (Anti-obesity Medication) Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Forecast by Type (2023-2028) & (K Units)

Table 85. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Forecast by Application (2023-2028) & (K Units)

Table 89. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share Forecast by Application (2023-2028)

Table 92. Zafgan Basic Information, Anti-Obesity Drugs (Anti-obesity Medication) Manufacturing Base, Sales Area and Its Competitors

Table 93. Zafgan Anti-Obesity Drugs (Anti-obesity Medication) Product Offered

Table 94. Zafgan Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 95. Zafgan Main Business

Table 96. Zafgan Latest Developments

Table 97. Vivus Basic Information, Anti-Obesity Drugs (Anti-obesity Medication) Manufacturing Base, Sales Area and Its Competitors

Table 98. Vivus Anti-Obesity Drugs (Anti-obesity Medication) Product Offered

Table 99. Vivus Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 100. Vivus Main Business

Table 101. Vivus Latest Developments

Table 102. Shionogi Basic Information, Anti-Obesity Drugs (Anti-obesity Medication) Manufacturing Base, Sales Area and Its Competitors

Table 103. Shionogi Anti-Obesity Drugs (Anti-obesity Medication) Product Offered

Table 104. Shionogi Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 105. Shionogi Main Business

Table 106. Shionogi Latest Developments

Table 107. Sanofi Basic Information, Anti-Obesity Drugs (Anti-obesity Medication) Manufacturing Base, Sales Area and Its Competitors

Table 108. Sanofi Anti-Obesity Drugs (Anti-obesity Medication) Product Offered

Table 109. Sanofi Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 110. Sanofi Main Business

Table 111. Sanofi Latest Developments

Table 112. Rhythm Pharmaceuticals Basic Information, Anti-Obesity Drugs (Anti-obesity Medication) Manufacturing Base, Sales Area and Its Competitors

Table 113. Rhythm Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Product Offered

Table 114. Rhythm Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 115. Rhythm Pharmaceuticals Main Business

Table 116. Rhythm Pharmaceuticals Latest Developments

Table 117. Pfizer Basic Information, Anti-Obesity Drugs (Anti-obesity Medication) Manufacturing Base, Sales Area and Its Competitors

Table 118. Pfizer Anti-Obesity Drugs (Anti-obesity Medication) Product Offered

Table 119. Pfizer Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 120. Pfizer Main Business

Table 121. Pfizer Latest Developments

Table 122. Orexigen Therapeutics Basic Information, Anti-Obesity Drugs (Anti-obesity Medication) Manufacturing Base, Sales Area and Its Competitors

Table 123. Orexigen Therapeutics Anti-Obesity Drugs (Anti-obesity Medication) Product Offered

Table 124. Orexigen Therapeutics Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 125. Orexigen Therapeutics Main Business

Table 126. Orexigen Therapeutics Latest Developments

Table 127. Novo Nordisk Basic Information, Anti-Obesity Drugs (Anti-obesity Medication) Manufacturing Base, Sales Area and Its Competitors

Table 128. Novo Nordisk Anti-Obesity Drugs (Anti-obesity Medication) Product Offered

Table 129. Novo Nordisk Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 130. Novo Nordisk Main Business

Table 131. Novo Nordisk Latest Developments

Table 132. Norgine Basic Information, Anti-Obesity Drugs (Anti-obesity Medication) Manufacturing Base, Sales Area and Its Competitors

Table 133. Norgine Anti-Obesity Drugs (Anti-obesity Medication) Product Offered

Table 134. Norgine Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 135. Norgine Main Business

Table 136. Norgine Latest Developments

Table 137. Nalpropion Pharmaceuticals Inc. Basic Information, Anti-Obesity Drugs (Anti-obesity Medication) Manufacturing Base, Sales Area and Its Competitors

Table 138. Nalpropion Pharmaceuticals Inc. Anti-Obesity Drugs (Anti-obesity Medication) Product Offered

Table 139. Nalpropion Pharmaceuticals Inc. Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 140. Nalpropion Pharmaceuticals Inc. Main Business

Table 141. Nalpropion Pharmaceuticals Inc. Latest Developments

Table 142. Merck Basic Information, Anti-Obesity Drugs (Anti-obesity Medication) Manufacturing Base, Sales Area and Its Competitors

Table 143. Merck Anti-Obesity Drugs (Anti-obesity Medication) Product Offered

Table 144. Merck Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 145. Merck Main Business

Table 146. Merck Latest Developments

Table 147. GlaxoSmithKline Basic Information, Anti-Obesity Drugs (Anti-obesity Medication) Manufacturing Base, Sales Area and Its Competitors

Table 148. GlaxoSmithKline Anti-Obesity Drugs (Anti-obesity Medication) Product Offered

Table 149. GlaxoSmithKline Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 150. GlaxoSmithKline Main Business

Table 151. GlaxoSmithKline Latest Developments

Table 152. F.Hoffmann-La Roche Basic Information, Anti-Obesity Drugs (Anti-obesity Medication) Manufacturing Base, Sales Area and Its Competitors

Table 153. F.Hoffmann-La Roche Anti-Obesity Drugs (Anti-obesity Medication) Product Offered

Table 154. F.Hoffmann-La Roche Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 155. F.Hoffmann-La Roche Main Business

Table 156. F.Hoffmann-La Roche Latest Developments

Table 157. Eisai Basic Information, Anti-Obesity Drugs (Anti-obesity Medication) Manufacturing Base, Sales Area and Its Competitors

Table 158. Eisai Anti-Obesity Drugs (Anti-obesity Medication) Product Offered

Table 159. Eisai Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 160. Eisai Main Business

Table 161. Eisai Latest Developments

Table 162. Boehringer Ingelheim Basic Information, Anti-Obesity Drugs (Anti-obesity Medication) Manufacturing Base, Sales Area and Its Competitors

Table 163. Boehringer Ingelheim Anti-Obesity Drugs (Anti-obesity Medication) Product Offered

Table 164. Boehringer Ingelheim Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 165. Boehringer Ingelheim Main Business

Table 166. Boehringer Ingelheim Latest Developments

Table 167. Bayer AG Basic Information, Anti-Obesity Drugs (Anti-obesity Medication) Manufacturing Base, Sales Area and Its Competitors

Table 168. Bayer AG Anti-Obesity Drugs (Anti-obesity Medication) Product Offered

Table 169. Bayer AG Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 170. Bayer AG Main Business

Table 171. Bayer AG Latest Developments

Table 172. AstraZeneca Basic Information, Anti-Obesity Drugs (Anti-obesity Medication) Manufacturing Base, Sales Area and Its Competitors

Table 173. AstraZeneca Anti-Obesity Drugs (Anti-obesity Medication) Product Offered

Table 174. AstraZeneca Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 175. AstraZeneca Main Business

Table 176. AstraZeneca Latest Developments

Table 177. Arena Pharmaceuticals Basic Information, Anti-Obesity Drugs (Anti-obesity Medication) Manufacturing Base, Sales Area and Its Competitors

Table 178. Arena Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Product Offered

Table 179. Arena Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 180. Arena Pharmaceuticals Main Business

Table 181. Arena Pharmaceuticals Latest Developments

Table 182. Amylin Basic Information, Anti-Obesity Drugs (Anti-obesity Medication) Manufacturing Base, Sales Area and Its Competitors

Table 183. Amylin Anti-Obesity Drugs (Anti-obesity Medication) Product Offered

Table 184. Amylin Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 185. Amylin Main Business

Table 186. Amylin Latest Developments

Table 187. Alizyme Basic Information, Anti-Obesity Drugs (Anti-obesity Medication) Manufacturing Base, Sales Area and Its Competitors

Table 188. Alizyme Anti-Obesity Drugs (Anti-obesity Medication) Product Offered

Table 189. Alizyme Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 190. Alizyme Main Business

Table 191. Alizyme Latest Developments

List of Figures

Figure 1. Picture of Anti-Obesity Drugs (Anti-obesity Medication)

Figure 2. Anti-Obesity Drugs (Anti-obesity Medication) Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Anti-Obesity Drugs (Anti-obesity Medication) Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Prescription Drugs

Figure 10. Product Picture of OTC Drugs

Figure 11. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Type in 2021

Figure 12. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share by Type (2017-2022)

Figure 13. Anti-Obesity Drugs (Anti-obesity Medication) Consumed in Childhood (0-6)

Figure 14. Global Anti-Obesity Drugs (Anti-obesity Medication) Market: Childhood (0-6) (2017-2022) & (K Units)

Figure 15. Anti-Obesity Drugs (Anti-obesity Medication) Consumed in Juvenile (7-17)

Figure 16. Global Anti-Obesity Drugs (Anti-obesity Medication) Market: Juvenile (7-17) (2017-2022) & (K Units)

Figure 17. Anti-Obesity Drugs (Anti-obesity Medication) Consumed in Youth (18-40)

Figure 18. Global Anti-Obesity Drugs (Anti-obesity Medication) Market: Youth (18-40) (2017-2022) & (K Units)

Figure 19. Anti-Obesity Drugs (Anti-obesity Medication) Consumed in Middle Aged (41-60)

Figure 20. Global Anti-Obesity Drugs (Anti-obesity Medication) Market: Middle Aged (41-60) (2017-2022) & (K Units)

Figure 21. Anti-Obesity Drugs (Anti-obesity Medication) Consumed in Elderly (Above 60)

Figure 22. Global Anti-Obesity Drugs (Anti-obesity Medication) Market: Elderly (Above 60) (2017-2022) & (K Units)

Figure 23. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Application (2017-2022)

Figure 24. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share by Application in 2021

Figure 25. Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market by Company in 2021 ($ Million)

Figure 26. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share by Company in 2021

Figure 27. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Geographic Region (2017-2022)

Figure 28. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share by Geographic Region in 2021

Figure 29. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Region (2017-2022)

Figure 30. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share by Country/Region in 2021

Figure 31. Americas Anti-Obesity Drugs (Anti-obesity Medication) Sales 2017-2022 (K Units)

Figure 32. Americas Anti-Obesity Drugs (Anti-obesity Medication) Revenue 2017-2022 ($ Millions)

Figure 33. APAC Anti-Obesity Drugs (Anti-obesity Medication) Sales 2017-2022 (K Units)

Figure 34. APAC Anti-Obesity Drugs (Anti-obesity Medication) Revenue 2017-2022 ($ Millions)

Figure 35. Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales 2017-2022 (K Units)

Figure 36. Europe Anti-Obesity Drugs (Anti-obesity Medication) Revenue 2017-2022 ($ Millions)

Figure 37. Middle East & Africa Anti-Obesity Drugs (Anti-obesity Medication) Sales 2017-2022 (K Units)

Figure 38. Middle East & Africa Anti-Obesity Drugs (Anti-obesity Medication) Revenue 2017-2022 ($ Millions)

Figure 39. Americas Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Country in 2021

Figure 40. Americas Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share by Country in 2021

Figure 41. United States Anti-Obesity Drugs (Anti-obesity Medication) Revenue Growth 2017-2022 ($ Millions)

Figure 42. Canada Anti-Obesity Drugs (Anti-obesity Medication) Revenue Growth 2017-2022 ($ Millions)

Figure 43. Mexico Anti-Obesity Drugs (Anti-obesity Medication) Revenue Growth 2017-2022 ($ Millions)

Figure 44. Brazil Anti-Obesity Drugs (Anti-obesity Medication) Revenue Growth 2017-2022 ($ Millions)

Figure 45. APAC Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Region in 2021

Figure 46. APAC Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share by Regions in 2021

Figure 47. China Anti-Obesity Drugs (Anti-obesity Medication) Revenue Growth 2017-2022 ($ Millions)

Figure 48. Japan Anti-Obesity Drugs (Anti-obesity Medication) Revenue Growth 2017-2022 ($ Millions)

Figure 49. South Korea Anti-Obesity Drugs (Anti-obesity Medication) Revenue Growth 2017-2022 ($ Millions)

Figure 50. Southeast Asia Anti-Obesity Drugs (Anti-obesity Medication) Revenue Growth 2017-2022 ($ Millions)

Figure 51. India Anti-Obesity Drugs (Anti-obesity Medication) Revenue Growth 2017-2022 ($ Millions)

Figure 52. Australia Anti-Obesity Drugs (Anti-obesity Medication) Revenue Growth 2017-2022 ($ Millions)

Figure 53. Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Country in 2021

Figure 54. Europe Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share by Country in 2021

Figure 55. Germany Anti-Obesity Drugs (Anti-obesity Medication) Revenue Growth 2017-2022 ($ Millions)

Figure 56. France Anti-Obesity Drugs (Anti-obesity Medication) Revenue Growth 2017-2022 ($ Millions)

Figure 57. UK Anti-Obesity Drugs (Anti-obesity Medication) Revenue Growth 2017-2022 ($ Millions)

Figure 58. Italy Anti-Obesity Drugs (Anti-obesity Medication) Revenue Growth 2017-2022 ($ Millions)

Figure 59. Russia Anti-Obesity Drugs (Anti-obesity Medication) Revenue Growth 2017-2022 ($ Millions)

Figure 60. Middle East & Africa Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Country in 2021

Figure 61. Middle East & Africa Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share by Country in 2021

Figure 62. Egypt Anti-Obesity Drugs (Anti-obesity Medication) Revenue Growth 2017-2022 ($ Millions)

Figure 63. South Africa Anti-Obesity Drugs (Anti-obesity Medication) Revenue Growth 2017-2022 ($ Millions)

Figure 64. Israel Anti-Obesity Drugs (Anti-obesity Medication) Revenue Growth 2017-2022 ($ Millions)

Figure 65. Turkey Anti-Obesity Drugs (Anti-obesity Medication) Revenue Growth 2017-2022 ($ Millions)

Figure 66. GCC Country Anti-Obesity Drugs (Anti-obesity Medication) Revenue Growth 2017-2022 ($ Millions)

Figure 67. Manufacturing Cost Structure Analysis of Anti-Obesity Drugs (Anti-obesity Medication) in 2021

Figure 68. Manufacturing Process Analysis of Anti-Obesity Drugs (Anti-obesity Medication)

Figure 69. Industry Chain Structure of Anti-Obesity Drugs (Anti-obesity Medication)

Figure 70. Channels of Distribution

Figure 71. Distributors Profiles